|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61P 7/00 | |||
| A61P 37/02 | |||
| C07K 16/18 | |||
| A61K 38/12 | |||
| A61K 38/17 | |||
| A61K 45/06 | |||
| A61K 31/245 | |||
| A61K 39/395 |
| (11) | Number of the document | 2542255 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11751164.2 |
| Date of filing the European patent application | 2011-03-01 | |
| (97) | Date of publication of the European application | 2013-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/026602 |
| Date | 2011-03-01 |
| (87) | Number | WO 2011/109338 |
| Date | 2011-09-09 |
| (30) | Number | Date | Country code |
| 309393 P | 2010-03-01 | US |
| (72) |
MAGRO, Cynthia, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
352 Knotter Drive, Cheshire, CT 06410,
US
|
| (54) | COMPOSITIONS FOR TREATING DEGOS` DISEASE |
| COMPOSITIONS FOR TREATING DEGOS` DISEASE |